Becton Gets Emergency Use for First At-Home COVID-19 Test to Use Smartphone

  BD Veritor™ At-Home COVID-19 Test is Over-the-Counter, Rapid Antigen Test Using Scanwell Health Mobile App to Deliver Reliable Results in 15 Minutes

- Digitally Read Test Provides Clear Positive or Negative Confirmation of COVID-19 Status

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the BD Veritor™ At-Home COVID-19 Test — the first at-home COVID-19 rapid antigen test to use computer vision technology in a smartphone to interpret and provide a digital display of testing results. The test does not require a prescription, a laboratory or a long wait for results.

https://finance.yahoo.com/news/bd-receives-emergency-authorization-first-201000571.html